UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 641

Sortiert nach

501 Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzumab in Her2-positive Breast Cancer

European journal of cancer (1990), 2012-11, Vol.48, p.155-155

2012

Volltextzugriff (PDF)

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

Carcinogenesis (New York), 1999-10, Vol.20 (10), p.1905-1911

1999

Volltextzugriff (PDF)

Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines

British journal of cancer, 1998-09, Vol.78 (6), p.710-717

1998

Volltextzugriff (PDF)

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Breast cancer research and treatment, 1998, Vol.47 (1), p.9-16

1998

Volltextzugriff (PDF)

Preface: Meeting Report ISOT-2022, Nagpur:Collaborative Meeting Involving International, National, and Regional Transplant Organizations

Transplantation proceedings, 2023-06, Vol.55 (5), p.1303-1304

2023

Volltextzugriff (PDF)

Expression of Microtubule-Associated Protein 2 in Benign and Malignant Melanocytes : Implications for Differentiation and Progression of Cutaneous Melanoma

The American journal of pathology, 2001-06, Vol.158 (6), p.2107-2115

2001

Volltextzugriff (PDF)

Prognostic markers in node‐negative breast cancer: A prospective study

Cytometry. Part B, Clinical cytometry, 2004-05, Vol.59B (1), p.24-31

2004

Volltextzugriff (PDF)

Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells

Cancer research (Chicago, Ill.), 1999-12, Vol.59 (24), p.6171-6177

1999

Volltextzugriff (PDF)

Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays

Cancer research (Chicago, Ill.), 1992-10, Vol.52 (19), p.5198-5203

1992

Volltextzugriff (PDF)

DNA strand breaks and cell cycle perturbation in Herceptin treated breast cancer cell lines

Breast cancer research and treatment, 2001-11, Vol.70 (2), p.123-129

2001

Volltextzugriff (PDF)

Analysis of isoflavones by capillary electrophoresis

Journal of Chromatography A, 1994-09, Vol.680 (1), p.181-185

1994

Volltextzugriff (PDF)

nm23—Relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients

Cancer, 1997-03, Vol.79 (6), p.1158-1165

1997

Volltextzugriff (PDF)

Abstract P5-08-02: New target in the resistant mechanism to trastuzumab

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-08-02

2013

Volltextzugriff (PDF)

Malignant papillary cystic tumor of the pancreas

Cancer, 1990-07, Vol.66 (1), p.193-198

1990

Volltextzugriff (PDF)

Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors

Oncogene, 2003-09, Vol.22 (40), p.6194-6203

2003

Volltextzugriff (PDF)

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-09, Vol.90 (18), p.1346-1360

1998

Volltextzugriff (PDF)

Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: Clinical and biologic significance

American journal of obstetrics and gynecology, 1997-06, Vol.176 (6), p.1319-1327

1997

Volltextzugriff (PDF)

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

Cancer, 1989-11, Vol.64 (9), p.1894-1900

1989

Volltextzugriff (PDF)

Development of Herceptin resistance in breast cancer cells

Cytometry. Part A, 2004-02, Vol.57A (2), p.86-93

2004

Volltextzugriff (PDF)

Apparent age-related resistance of type II hippocampal corticosteroid receptors to down-regulation during chronic escape training

The Journal of neuroscience, 1989-09, Vol.9 (9), p.3237-3242

1989

Volltextzugriff (PDF)

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors

Cancer, 1989-01, Vol.63 (2), p.280-288

1989

Volltextzugriff (PDF)

Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine : implications for cell cytotoxicity

Cancer chemotherapy and pharmacology, 1995, Vol.35 (6), p.489-495

1995

Volltextzugriff (PDF)

Oligosaccharide Sequence of Human Breast Cancer Cell Heparan Sulfate with High Affinity for Laminin

The Journal of biological chemistry, 1998-08, Vol.273 (33), p.21111-21114

1998

Volltextzugriff (PDF)

Measurement of proliferation nuclear and membrane markers in tumor cells by flow cytometry

The journal of histochemistry and cytochemistry, 1991-08, Vol.39 (8), p.1125-1130

1991

Volltextzugriff (PDF)

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

The New England journal of medicine, 1994-05, Vol.330 (18), p.1260-1266

1994

Volltextzugriff (PDF)

1 – 25 von 641

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(494)
Mit Volltextzugriff
(602)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

501 Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzumab in Her2-positive Breast Cancer

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Preface: Meeting Report ISOT-2022, Nagpur:Collaborative Meeting Involving International, National, and Regional Transplant Organizations

Expression of Microtubule-Associated Protein 2 in Benign and Malignant Melanocytes : Implications for Differentiation and Progression of Cutaneous Melanoma

Prognostic markers in node‐negative breast cancer: A prospective study

Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells

Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays

DNA strand breaks and cell cycle perturbation in Herceptin treated breast cancer cell lines

Analysis of isoflavones by capillary electrophoresis

nm23—Relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients

Abstract P5-08-02: New target in the resistant mechanism to trastuzumab

Malignant papillary cystic tumor of the pancreas

Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: Clinical and biologic significance

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

Development of Herceptin resistance in breast cancer cells

Apparent age-related resistance of type II hippocampal corticosteroid receptors to down-regulation during chronic escape training

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors

Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine : implications for cell cytotoxicity

Oligosaccharide Sequence of Human Breast Cancer Cell Heparan Sulfate with High Affinity for Laminin

Measurement of proliferation nuclear and membrane markers in tumor cells by flow cytometry

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

Suchergebnisse filtern